 | • レポートコード：20QY06-00100 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、5ヌクレオチダーゼのグローバル市場について種類別（CPX-006、IPH-53、AB-680、BMS-986179、その他）、用途別（大腸がん、卵管がん、胃がん、転移性大腸がん、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・5ヌクレオチダーゼ市場の概要 ・世界の主要地域別5ヌクレオチダーゼ市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の5ヌクレオチダーゼ市場規模2015-2026：種類別（CPX-006、IPH-53、AB-680、BMS-986179、その他） ・世界の5ヌクレオチダーゼ市場規模2015-2026：用途別（大腸がん、卵管がん、胃がん、転移性大腸がん、その他） ・5ヌクレオチダーゼの北米市場規模2015-2020 ・5ヌクレオチダーゼのヨーロッパ市場規模2015-2020 ・5ヌクレオチダーゼの中国市場規模2015-2020 ・5ヌクレオチダーゼの日本市場規模2015-2020 ・5ヌクレオチダーゼの東南アジア市場規模2015-2020 ・5ヌクレオチダーゼのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Bristol-Myers Squibb Co、Corvus Pharmaceuticals Inc、Innate Pharma SA、MedImmune LLC、Surface Oncology Inc） ・5ヌクレオチダーゼの製造コスト分析 ・販売チャネル、流通業者、顧客 ・5ヌクレオチダーゼの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global 5 Nucleotidase Market
The global 5 Nucleotidase market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global 5 Nucleotidase Scope and Market Size
The global 5 Nucleotidase market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global 5 Nucleotidase market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the 5 Nucleotidase market is segmented into
CPX-006
IPH-53
AB-680
BMS-986179
Others
Segment by Application, the 5 Nucleotidase market is segmented into
Colorectal Cancer
Fallopian Tube Cancer
Gastric Cancer
Metastatic Colorectal Cancer
Others
The 5 Nucleotidase market is analysed and market size information is provided by regions (countries). Segment by Application, the 5 Nucleotidase market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and 5 Nucleotidase Market Share Analysis
5 Nucleotidase market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in 5 Nucleotidase business, the date to enter into the 5 Nucleotidase market, 5 Nucleotidase product introduction, recent developments, etc.
The major vendors covered:
Bristol-Myers Squibb Co
Corvus Pharmaceuticals Inc
Innate Pharma SA
MedImmune LLC
Surface Oncology Inc
…
Table of Contents
1 5 Nucleotidase Market Overview
1.1 5 Nucleotidase Product Scope
1.2 5 Nucleotidase Segment by Type
1.2.1 Global 5 Nucleotidase Sales by Type (2020-2026)
1.2.2 CPX-006
1.2.3 IPH-53
1.2.4 AB-680
1.2.5 BMS-986179
1.2.6 Others
1.3 5 Nucleotidase Segment by Application
1.3.1 Global 5 Nucleotidase Sales Comparison by Application (2020-2026)
1.3.2 Colorectal Cancer
1.3.3 Fallopian Tube Cancer
1.3.4 Gastric Cancer
1.3.5 Metastatic Colorectal Cancer
1.3.6 Others
1.4 5 Nucleotidase Market Estimates and Forecasts (2015-2026)
1.4.1 Global 5 Nucleotidase Sales Growth Rate (2015-2026)
1.4.2 Global 5 Nucleotidase Revenue and Growth Rate (2015-2026)
1.4.3 Global 5 Nucleotidase Price Trends (2015-2026)
2 5 Nucleotidase Estimate and Forecast by Region
2.1 Global 5 Nucleotidase Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global 5 Nucleotidase Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global 5 Nucleotidase Sales Market Share by Region (2015-2020)
2.2.2 Global 5 Nucleotidase Revenue Market Share by Region (2015-2020)
2.3 Global 5 Nucleotidase Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global 5 Nucleotidase Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global 5 Nucleotidase Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States 5 Nucleotidase Estimates and Projections (2015-2026)
2.4.2 Europe 5 Nucleotidase Estimates and Projections (2015-2026)
2.4.3 China 5 Nucleotidase Estimates and Projections (2015-2026)
2.4.4 Japan 5 Nucleotidase Estimates and Projections (2015-2026)
2.4.5 Southeast Asia 5 Nucleotidase Estimates and Projections (2015-2026)
2.4.6 India 5 Nucleotidase Estimates and Projections (2015-2026)
3 Global 5 Nucleotidase Competition Landscape by Players
3.1 Global Top 5 Nucleotidase Players by Sales (2015-2020)
3.2 Global Top 5 Nucleotidase Players by Revenue (2015-2020)
3.3 Global 5 Nucleotidase Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 5 Nucleotidase as of 2019)
3.4 Global 5 Nucleotidase Average Price by Company (2015-2020)
3.5 Manufacturers 5 Nucleotidase Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key 5 Nucleotidase Players (Opinion Leaders)
4 Global 5 Nucleotidase Market Size by Type
4.1 Global 5 Nucleotidase Historic Market Review by Type (2015-2020)
4.1.1 Global 5 Nucleotidase Sales Market Share by Type (2015-2020)
4.1.2 Global 5 Nucleotidase Revenue Market Share by Type (2015-2020)
4.1.3 Global 5 Nucleotidase Price by Type (2014-2020)
4.2 Global 5 Nucleotidase Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global 5 Nucleotidase Sales Forecast by Type (2021-2026)
4.2.2 Global 5 Nucleotidase Revenue Forecast by Type (2021-2026)
4.2.3 Global 5 Nucleotidase Price Forecast by Type (2021-2026)
5 Global 5 Nucleotidase Market Size by Application
5.1 Global 5 Nucleotidase Historic Market Review by Application (2015-2020)
5.1.1 Global 5 Nucleotidase Sales Market Share by Application (2015-2020)
5.1.2 Global 5 Nucleotidase Revenue Market Share by Application (2015-2020)
5.1.3 Global 5 Nucleotidase Price by Application (2015-2020)
5.2 Global 5 Nucleotidase Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global 5 Nucleotidase Sales Forecast by Application (2021-2026)
5.2.2 Global 5 Nucleotidase Revenue Forecast by Application (2021-2026)
5.2.3 Global 5 Nucleotidase Price Forecast by Application (2021-2026)
3 North America 5 Nucleotidase Market Facts & Figures
3.2 North America 5 Nucleotidase Sales Market Share by Company (2015-2020)
3.3 North America 5 Nucleotidase Sales Market Share by Type (2015-2020)
3.4 North America 5 Nucleotidase Sales Market Share by Application (2015-2020)
4 Europe 5 Nucleotidase Market Facts & Figures
4.2 Europe 5 Nucleotidase Sales Market Share by Company (2015-2020)
4.3 Europe 5 Nucleotidase Sales Market Share by Type (2015-2020)
4.4 Europe 5 Nucleotidase Sales Market Share by Application (2015-2020)
5 China 5 Nucleotidase Market Facts & Figures
5.2 China 5 Nucleotidase Sales Market Share by Company (2015-2020)
5.3 China 5 Nucleotidase Sales Market Share by Type (2015-2020)
5.4 China 5 Nucleotidase Sales Market Share by Application (2015-2020)
6 Japan 5 Nucleotidase Market Facts & Figures
6.2 Japan 5 Nucleotidase Sales Market Share by Company (2015-2020)
6.3 Japan 5 Nucleotidase Sales Market Share by Type (2015-2020)
6.4 Japan 5 Nucleotidase Sales Market Share by Application (2015-2020)
7 Southeast Asia 5 Nucleotidase Market Facts & Figures
7.2 Southeast Asia 5 Nucleotidase Sales Market Share by Company (2015-2020)
7.3 Southeast Asia 5 Nucleotidase Sales Market Share by Type (2015-2020)
7.4 Southeast Asia 5 Nucleotidase Sales Market Share by Application (2015-2020)
8 India 5 Nucleotidase Market Facts & Figures
8.2 India 5 Nucleotidase Sales Market Share by Company (2015-2020)
8.3 India 5 Nucleotidase Sales Market Share by Type (2015-2020)
8.4 India 5 Nucleotidase Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in 5 Nucleotidase Business
12.1 Bristol-Myers Squibb Co
12.1.1 Bristol-Myers Squibb Co 5 Nucleotidase Corporation Information
12.1.2 Bristol-Myers Squibb Co 5 Nucleotidase Business Overview and Total Revenue
12.1.3 Bristol-Myers Squibb Co 5 Nucleotidase Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bristol-Myers Squibb Co 5 Nucleotidase Products Offered
12.1.5 Bristol-Myers Squibb Co Recent Development
12.2 Corvus Pharmaceuticals Inc
12.2.1 Corvus Pharmaceuticals Inc 5 Nucleotidase Corporation Information
12.2.2 Corvus Pharmaceuticals Inc 5 Nucleotidase Business Overview and Total Revenue
12.2.3 Corvus Pharmaceuticals Inc 5 Nucleotidase Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Corvus Pharmaceuticals Inc 5 Nucleotidase Products Offered
12.2.5 Corvus Pharmaceuticals Inc Recent Development
12.3 Innate Pharma SA
12.3.1 Innate Pharma SA 5 Nucleotidase Corporation Information
12.3.2 Innate Pharma SA 5 Nucleotidase Business Overview and Total Revenue
12.3.3 Innate Pharma SA 5 Nucleotidase Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Innate Pharma SA 5 Nucleotidase Products Offered
12.3.5 Innate Pharma SA Recent Development
12.4 MedImmune LLC
12.4.1 MedImmune LLC 5 Nucleotidase Corporation Information
12.4.2 MedImmune LLC 5 Nucleotidase Business Overview and Total Revenue
12.4.3 MedImmune LLC 5 Nucleotidase Sales, Revenue and Gross Margin (2015-2020)
12.4.4 MedImmune LLC 5 Nucleotidase Products Offered
12.4.5 MedImmune LLC Recent Development
12.5 Surface Oncology Inc
12.5.1 Surface Oncology Inc 5 Nucleotidase Corporation Information
12.5.2 Surface Oncology Inc 5 Nucleotidase Business Overview and Total Revenue
12.5.3 Surface Oncology Inc 5 Nucleotidase Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Surface Oncology Inc 5 Nucleotidase Products Offered
12.5.5 Surface Oncology Inc Recent Development
…
13 5 Nucleotidase Manufacturing Cost Analysis
13.1 5 Nucleotidase Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of 5 Nucleotidase
13.4 5 Nucleotidase Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 5 Nucleotidase Distributors List
14.3 5 Nucleotidase Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global 5 Nucleotidase Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global 5 Nucleotidase Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. Global Market 5 Nucleotidase Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global 5 Nucleotidase Sales (K Pcs) by Region (2015-2020)
Table 5. Global 5 Nucleotidase Sales Market Share by Region (2015-2020)
Table 6. Global 5 Nucleotidase Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global 5 Nucleotidase Revenue Share by Region (2015-2020)
Table 8. Global 5 Nucleotidase Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global 5 Nucleotidase Sales Market Share Forecast by Region (2021-2026)
Table 10. Global 5 Nucleotidase Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global 5 Nucleotidase Revenue Share Forecast by Region (2021-2026)
Table 12. Global 5 Nucleotidase (K Pcs) of Key Companies (2015-2020)
Table 13. Global 5 Nucleotidase Sales Share by Company (2015-2020)
Table 14. Global 5 Nucleotidase Revenue (US$ Million) by Company (2015-2020)
Table 15. Global 5 Nucleotidase Revenue Share by Company (2015-2020)
Table 16. Global 5 Nucleotidase by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 5 Nucleotidase as of 2019)
Table 17. Global 5 Nucleotidase Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers 5 Nucleotidase Manufacturing Sites and Area Served
Table 19. Manufacturers 5 Nucleotidase Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key 5 Nucleotidase Players
Table 22. Global 5 Nucleotidase Sales (K Pcs) by Type (2015-2020)
Table 23. Global 5 Nucleotidase Sales Share by Type (2015-2020)
Table 24. Global 5 Nucleotidase Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global 5 Nucleotidase Price (K Pcs) by Type (2015-2020)
Table 26. Global 5 Nucleotidase Sales Share by Type (2021-2026)
Table 27. Global 5 Nucleotidase Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global 5 Nucleotidase Revenue Share by Type (2021-2026)
Table 29. Global 5 Nucleotidase Price (K Pcs) by Type (2021-2026)
Table 30. Global 5 Nucleotidase Sales (K Pcs) by Application (2015-2020)
Table 31. Global 5 Nucleotidase Sales Share by Application (2015-2020)
Table 32. Global 5 Nucleotidase Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global 5 Nucleotidase Price (K Pcs) by Application (2015-2020)
Table 34. Global 5 Nucleotidase Sales (K Pcs) by Application (2021-2026)
Table 35. Global 5 Nucleotidase Sales Share by Application (2021-2026)
Table 36. Global 5 Nucleotidase Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global 5 Nucleotidase Revenue Share by Application (2021-2026)
Table 38. Global 5 Nucleotidase Price (K Pcs) by Application (2021-2026)
Table 39. United States 5 Nucleotidase Sales (K Pcs) by Company (2015-2020)
Table 40. United States 5 Nucleotidase Sales Market Share by Company (2015-2020)
Table 41. United States 5 Nucleotidase Sales (K Pcs) by Type (2015-2020)
Table 42. United States 5 Nucleotidase Sales Market Share by Type (2015-2020)
Table 43. United States 5 Nucleotidase Sales (K Pcs) by Application (2015-2020)
Table 44. United States 5 Nucleotidase Sales Market Share by Application (2015-2020)
Table 45. Europe 5 Nucleotidase Sales (K Pcs) by Company (2015-2020)
Table 46. Europe 5 Nucleotidase Sales Market Share by Company (2015-2020)
Table 47. Europe 5 Nucleotidase Sales (K Pcs) by Type (2015-2020)
Table 48. Europe 5 Nucleotidase Sales Market Share by Type (2015-2020)
Table 49. Europe 5 Nucleotidase Sales (K Pcs) by Application (2015-2020)
Table 50. Europe 5 Nucleotidase Sales Market Share by Type (2015-2020)
Table 51. China 5 Nucleotidase Sales (K Pcs) by Company (2015-2020)
Table 52. China 5 Nucleotidase Sales Market Share by Company (2015-2020)
Table 53. China 5 Nucleotidase Sales (K Pcs) by Type (2015-2020)
Table 54. China 5 Nucleotidase Sales Market Share by Type (2015-2020)
Table 55. China 5 Nucleotidase Sales (K Pcs) by Application (2015-2020)
Table 56. China 5 Nucleotidase Sales Market Share by Application (2015-2020)
Table 57. Japan 5 Nucleotidase Sales (K Pcs) by Company (2015-2020)
Table 58. Japan 5 Nucleotidase Sales Market Share by Company (2015-2020)
Table 59. Japan 5 Nucleotidase Sales (K Pcs) by Type (2015-2020)
Table 60. Japan 5 Nucleotidase Sales Market Share by Type (2015-2020)
Table 61. Japan 5 Nucleotidase Sales (K Pcs) by Application (2015-2020)
Table 62. Japan 5 Nucleotidase Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia 5 Nucleotidase Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia 5 Nucleotidase Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia 5 Nucleotidase Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia 5 Nucleotidase Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia 5 Nucleotidase Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia 5 Nucleotidase Sales Market Share by Application (2015-2020)
Table 69. India 5 Nucleotidase Sales (K Pcs) by Company (2015-2020)
Table 70. India 5 Nucleotidase Sales Market Share by Company (2015-2020)
Table 71. India 5 Nucleotidase Sales (K Pcs) by Type (2015-2020)
Table 72. India 5 Nucleotidase Sales Market Share by Type (2015-2020)
Table 73. India 5 Nucleotidase Sales (K Pcs) by Application (2015-2020)
Table 74. India 5 Nucleotidase Sales Market Share by Application (2015-2020)
Table 75. Bristol-Myers Squibb Co Corporation Information
Table 76. Bristol-Myers Squibb Co Description and Business Overview
Table 77. Bristol-Myers Squibb Co 5 Nucleotidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Bristol-Myers Squibb Co 5 Nucleotidase Product
Table 79. Bristol-Myers Squibb Co Recent Development
Table 80. Corvus Pharmaceuticals Inc Corporation Information
Table 81. Corvus Pharmaceuticals Inc Description and Business Overview
Table 82. Corvus Pharmaceuticals Inc 5 Nucleotidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Corvus Pharmaceuticals Inc 5 Nucleotidase Product
Table 84. Corvus Pharmaceuticals Inc Recent Development
Table 85. Innate Pharma SA Corporation Information
Table 86. Innate Pharma SA Description and Business Overview
Table 87. Innate Pharma SA 5 Nucleotidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Innate Pharma SA 5 Nucleotidase Product
Table 89. Innate Pharma SA Recent Development
Table 90. MedImmune LLC Corporation Information
Table 91. MedImmune LLC Description and Business Overview
Table 92. MedImmune LLC 5 Nucleotidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. MedImmune LLC 5 Nucleotidase Product
Table 94. MedImmune LLC Recent Development
Table 95. Surface Oncology Inc Corporation Information
Table 96. Surface Oncology Inc Description and Business Overview
Table 97. Surface Oncology Inc 5 Nucleotidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Surface Oncology Inc 5 Nucleotidase Product
Table 99. Surface Oncology Inc Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. 5 Nucleotidase Distributors List
Table 103. 5 Nucleotidase Customers List
Table 104. Market Key Trends
Table 105. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 106. Key Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. 5 Nucleotidase Product Picture
Figure 2. Global 5 Nucleotidase Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global 5 Nucleotidase Market Share by Application in 2020 & 2026
Figure 6. Colorectal Cancer Examples
Figure 7. Fallopian Tube Cancer Examples
Figure 8. Gastric Cancer Examples
Figure 9. Metastatic Colorectal Cancer Examples
Figure 10. Others Examples
Figure 11. Global 5 Nucleotidase Sales (K Pcs) Growth Rate (2015-2026)
Figure 12. Global 5 Nucleotidase Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global 5 Nucleotidase Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 14. Global 5 Nucleotidase Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global 5 Nucleotidase Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States 5 Nucleotidase Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States 5 Nucleotidase Sales (K Pcs) Growth Rate (2015-2026)
Figure 18. Europe 5 Nucleotidase Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe 5 Nucleotidase Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China 5 Nucleotidase Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China 5 Nucleotidase Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan 5 Nucleotidase Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan 5 Nucleotidase Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia 5 Nucleotidase Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia 5 Nucleotidase Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India 5 Nucleotidase Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India 5 Nucleotidase Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest 5 Nucleotidase Players Market Share by Revenue in 5 Nucleotidase 2015 & 2019
Figure 29. 5 Nucleotidase Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global 5 Nucleotidase Revenue Share by Type (2015-2020)
Figure 31. Global 5 Nucleotidase Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global 5 Nucleotidase Revenue Share by Application (2015-2020)
Figure 33. Global 5 Nucleotidase Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States 5 Nucleotidase Sales Market Share by Type in 2019
Figure 35. United States 5 Nucleotidase Sales Market Share by Type in 2019
Figure 36. Europe 5 Nucleotidase Sales Market Share by Company in 2019
Figure 37. Europe 5 Nucleotidase Sales Market Share by Type in 2019
Figure 38. Europe 5 Nucleotidase Sales Market Share by Application in 2019
Figure 39. China 5 Nucleotidase Sales Market Share by Company in 2019
Figure 40. China 5 Nucleotidase Sales Market Share by Type in 2019
Figure 41. China 5 Nucleotidase Sales Market Share by Application in 2019
Figure 42. Japan 5 Nucleotidase Sales Market Share by Company in 2019
Figure 43. Japan 5 Nucleotidase Sales Market Share by Type in 2019
Figure 44. Japan 5 Nucleotidase Sales Market Share by Application in 2019
Figure 45. Southeast Asia 5 Nucleotidase Sales Market Share by Company in 2019
Figure 46. Southeast Asia 5 Nucleotidase Sales Market Share by Type in 2019
Figure 47. Southeast Asia 5 Nucleotidase Sales Market Share by Application in 2019
Figure 48. India 5 Nucleotidase Sales Market Share by Company in 2019
Figure 49. India 5 Nucleotidase Sales Market Share by Type in 2019
Figure 50. India 5 Nucleotidase Sales Market Share by Application in 2019
Figure 51. Bristol-Myers Squibb Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Corvus Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Innate Pharma SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. MedImmune LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Surface Oncology Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of 5 Nucleotidase
Figure 58. Manufacturing Process Analysis of 5 Nucleotidase
Figure 59. 5 Nucleotidase Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
転移性大腸がん手術の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Metastatic Colorectal Cancer Surgery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metastat…- 大腸がんの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Colorectal Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.1% in the forecast period of 2020 to 2025 and will expected to reach USD 9118.8 million by 2025, from USD 8386.1 million in 2019. The Colorectal Cancer …
- 大腸がん診断＆治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Colorectal Cancer Diagnosis and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …
- 肛門がん及び結腸直腸がんの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Anal and Colorectal Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anal and Colorecta…
- 癌用バイオマーカーの世界市場レポート2020 Market Analysis and Insights: Global Cancer Biomarkers Market The global Cancer Biomarkers market was valued at US$ 11710 million in 2019 and will reach US$ 18790 million by the end of 2026, growing at a CAGR of 6.9% during 2020-2026. Global Cancer Biomarkers Scope and Market Size The global Cancer …